Several Indian companies reported their June-quarter earnings on Wednesday, August 5, 2026, while others are set to announce results in the coming days. The results span multiple sectors — from specialty chemicals and pharmaceuticals to financial services and capital goods — providing a snapshot of corporate performance amid the current earnings season. The following stocks are in focus for August 6.

Navin Fluorine International Ltd

The specialty fluorochemicals manufacturer reported a consolidated net profit of ₹243.3 crore for the quarter ended June 30, 2026, more than doubling from ₹117.2 crore in the corresponding period last year, reflecting a significant improvement in earnings.

Cummins India

The engine and power generation equipment manufacturer delivered a mixed June-quarter performance, posting stronger-than-expected revenue growth but falling short of Street estimates on profitability as operating margins came under pressure. Standalone revenue rose 17.9% year-on-year to ₹3,426 crore, ahead of CNBC-TV18's estimate of ₹3,286 crore, indicating healthy demand across key domestic businesses. However, net profit declined 7.9% to ₹543 crore, well below the Street's expectation of ₹652 crore.

PB Fintech

The parent company of Policybazaar and Paisabazaar, two of India's largest online platforms for insurance and credit products, reported a 92.4% year-on-year rise in consolidated net profit for the quarter ended June, driven by sustained growth across its insurance and credit businesses. The performance reflects the broader expansion of India's digital financial services ecosystem, where online distribution platforms have been gaining share in insurance intermediation and credit facilitation.

Bayer CropScience

The life sciences company reported a 15.4% year-on-year increase in net profit for the June quarter, supported by stronger margins and a one-time gain, even as revenue declined during the period.

JK Lakshmi Cement

The cement manufacturer posted a net profit of ₹108 crore for the quarter ended June 30, 2026, down 28.1% from ₹150 crore in the corresponding quarter last year.

Neuland Laboratories

The active pharmaceutical ingredient manufacturer reported a net profit of ₹148 crore for the quarter ended June 30, 2026, compared with ₹14 crore in the same period last year. Revenue from operations more than doubled during the quarter, rising to ₹641.5 crore from ₹292.7 crore a year earlier.

Cohance Lifesciences

The firm received a Form 483 containing five observations from the United States Food and Drug Administration (USFDA) following an inspection of its manufacturing facility in Hyderabad, the company disclosed in a regulatory filing. A Form 483 is issued when FDA inspectors identify conditions that may constitute violations of the Food, Drug, and Cosmetic Act or related regulations. Companies are required to respond with corrective and preventive action plans, though the observations do not in themselves trigger enforcement action.

SIS Ltd

The firm posted a 9.4% year-on-year increase in consolidated net profit to ₹101.7 crore, while revenue rose 29.7% to ₹4,603.6 crore, reflecting robust growth across both its domestic and international security operations.

Aster DM Quality Care Limited

The healthcare major reported a sharp decline in net profit for the June quarter, even as the company delivered strong growth in revenue, patient volumes, and operating earnings. Revenue from operations increased 21.6% year-on-year to ₹1,311 crore from ₹1,078 crore a year earlier, supported by higher patient footfalls and improved performance across its hospital network.

Upcoming Q1 Earnings

Several companies are scheduled to announce their quarterly earnings on Thursday, including Advent Hotels International, The Anup Engineering, Aegis Logistics, Apollo Tyres, Bajaj Electricals, BirlaNu, BLS E-Services, and Blue Star.

Source: CNBC-TV18 Markets